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ABsTRACT
InTRODUCTIOn: in head and neck cancer patients, weight loss increases morbidity and mortality, and 
decreases treatment tolerance and quality of life. Early nutritional intervention has beneficial effects on 
these factors.
AIM: We observed patients’ weight courses after specialists’ care and surveyed nutrition-related docu-
mentation by general practitioners (GPs).
METHODs: From a Head and neck Oncology Centre (HnOC) study, 68 patients were asked to partici-
pate in an extended general practice cohort. Twenty-six patients participated in the prospective three-
monthly weight measurements during the year after HnOC care. We extracted nutritional information 
contained in referral letters (n=24) and medical records from the year before referral (n=45) and after 
HnOC care (n=26). An impaired nutritional status was assigned to weight loss ≥10% within six months or 
Body Mass index (BMi) <18.5 kg/m2 and ‘at risk’ to weight loss ≥5% but <10% within six months.
REsULTs: Three (12%) participants were nutritionally impaired and two (8%) were deemed ‘at risk’. 
Although GPs suspected a (pre-) malignancy in 11 cases (46%), only two (8%) documented weight loss 
or BMi and four (17%) nutrition-related complaints in their referral letters. Medical records more often 
contained information on nutrition-related complaints and tube feeding later in the disease course, as 
opposed to concern over weight loss or BMi.
DIsCUssIOn: Therefore, we call for nutritional management in general practice, by urging practitioners 
to assess patients’ nutritional status throughout the disease course and intervene if necessary. The pass-
ing on of related information in case of referral promotes continuity of care.
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Introduction
Nutritional deficiency ranges from micro- to 
multiple macronutrient shortages and results 
from physiologic (e.g. starvation) and/or patho-
logic conditions. Cachexia is such a complex 
pathologic hyper-metabolic condition defined by 
unintentional weight loss of greater than 5% of 
the premorbid weight within the previous six 
months.1 In general, the World Health Organiza-
tion defines underweight as a Body Mass Index 
(BMI) <18.5 kg/m2.2
Head and neck cancer patients are at evident 
risk for nutritional deficiency. Multiple factors 
undermine their nutritional status: a pre-
morbid lifestyle with poor dietary habits, often 
combined with excessive smoking and alcohol 
consumption,3 the tumour location, which causes 
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wHAT GAP THIs FILLs
What we already know: Preventing weight loss in head and neck cancer 
patients decreases morbidity and mortality, but above all increases treatment 
tolerance and quality of life. in the hospital, 30-50% of the head and neck 
cancer patients are undernourished, and weight even further decreased dur-
ing specialists’ care.
What this study adds: GPs documented weight loss, BMi, nutrition re-
lated complaints or interventions in the minority of these patients, while the 
year after hospital care 20% was ‘at risk’ or nutritionally impaired.
swallowing and food passage difficulties and, 
finally, the oncological treatment side effects.4
Weight loss in these patients increases morbidity 
and mortality and decreases treatment tolerance 
and overall quality of life.5-7 Early and intensive 
nutritional intervention has produced beneficial 
effects on weight loss, quality of life and physical 
function in oncology outpatients receiving radio-
therapy.8 Therefore, physicians should recognise 
and intervene early in cases of cachexia, starting 
with primary care, since in the hospital already 
30–50% of the head and neck cancer patients are 
undernourished. The current practice by general 
practitioners (GPs) of tracing or intervening in 
case of cachexia before referral and the neces-
sity of additional care after hospital treatment, 
has never been studied. 
Squamous cell carcinomas of the oral cavity, 
oropharynx and hypopharynx (OOH) are rela-
tively rare: on average a Dutch GP sees a ‘new’ 
OOH carcinoma patient every five to 10 years. 
However, GPs treat more cachexia-related diseases 
in their practices, such as COPD and heart 
failure. Since the risk for nutritional deficiency in 
head and neck cancer patients is generally known, 
we chose this group to exemplify current nutri-
tional management in general practice.
In a prospective, observational study performed 
at a Head and Neck Oncology Centre (HNOC), 
22 of the 68 (32%) OOH cancer patients were ‘at 
risk’ for, or suffered from, cachexia before treat-
ment and their weight decreased even further 
during specialists’ care.4
To illustrate the possible relevance and current 
nutritional management in general practice, we 
observed these patients’ weight courses after 
HNOC care and surveyed documentation of 
weight loss, BMI, nutrition-related complaints, 
and interventions by GPs the year before referral 
and after HNOC care. 
Methods
Study frame
Between March 2004 and May 2005, after 
approval of the local Committee on Research 
Involving Human Subjects, we extended a study 
performed in an HNOC to general practice. Of 
the 150 consecutive newly-referred patients with 
squamous cell OOH carcinoma, 116 were will-
ing to participate. However, 68 patients met the 
inclusion criteria; age ≥18 years, primary tumour 
stage II–IV (UICC TNM-tumour classification),9 
no history of malignancy and a primary curative 
treatment intent.4,10 At that time, all 68 patients 
signed an informed consent form for the use of 
their medical records.
Twelve patients already had died during onco-
logical treatment in the HNOC. In the Dutch 
health care system patients are registered with 
one general practice, which supplies the pro-
fessional medical care, including referrals to 
medical specialists. Therefore, we verified at 
general practices if patients were still alive, 
before asking them to participate. They re-
ceived an informed consent form by mail, to 
authorise three-monthly weight measurements 
during one year and/or the use of their medical 
records. We subsequently sent the signed con-
sent forms to the cooperating GPs. Before each 
weight measurement, the participant received 
a reminder letter with a weight registration 
form and pre-printed reply envelope. This form 
registered date, body weight (in kg) and dress 
(no or lightweight clothing, with/without shoes) 
and was filled out during each follow-up visit. 
For the 68 patients recruited in the HNOC, we 
looked up the primary referral letters available. 
We requested GPs to make available the medical 
record of participants and those who had died, 
from the year before referral and, if applicable, 
the year after HNOC care.
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Main outcome measures
In the HNOC, body height and weight had been 
measured by a dietician with a Seca-stadiometer 
and Seca-weighing scales (in metres (to two deci-
mal places) and kilograms (to one decimal place), 
respectively). During HNOC visits, question-
naires were filled out concerning nutritional 
information, such as energy (protein) supplements 
and tube feeding.4;10 After HNOC care, body 
weight was measured with GPs’ weighing scales 
(in kilograms (one decimal)) and adjusted by 0.3kg 
when the participant wore shoes. No correction 
for differences in dress were made.
We classified participants who lost 10% or more 
of their previous weight within six months, or 
those with a BMI <18.5 kg/m2 at the final weight 
measurement, as nutritionally impaired. If they 
lost between five and 10% of their previous weight 
within six months, they were classified as ‘at risk’ 
for an impaired nutritional status.
Documentation of information concerning the 
nutritional status in the referral letters and 
medical records were tallied and/or listed, also 
that related to comorbidity. This included weight 
loss or the BMI, nutrition-related complaints like 
swallowing or food passage difficulties and inter-
ventions such as GPs’ nutritional advice, energy 
(protein) supplements, treatment by a dietician 
and tube feeding (nasal passageway, Percutaneous 
Endoscopic Gastrostomy (PEG) or Percutaneous 
Radiological Gastrostomy (PRG)). The three-
monthly weight measurements documented in 
medical records were excluded, since these were 
not part of the usual care. The medical history, 
derived from medical records from the GPs and 
HNOC, was summed up to provide information 
on possible nutritional deficiency or fluid reten-
tion. Through referral letters, the differential 
diagnosis of the GPs was extracted. 
Statistical analysis
We analysed the data using the Statistical Package 
for Social Sciences (SPSS), version 12.0.1 (SPSS 
Corporation, Chicago, IL, USA). Characteristics 
of patients at intake and related documentation 
of the nutritional status in the referral letters 
and medical records were computed by frequency 
tables, and presented in numbers and percentages. 
The mean overall survival was the percentage of 
participants still alive from the date of intake in 
the HNOC until the first weight measurement in 
general practice. Weight change (%) within follow-
up intervals and BMI (kg/m2) at the final weight 
measurement were analysed and expressed by 
means with associated range and standard devia-
tions. With Chi-square we tested if differences oc-
curred in documentation quantity of information 
within medical records before referral and after 
HNOC care. The latter was calculated including 
and excluding documentation related to comor-
bidity. The level of significance was set at p<0.005. 
This study received ethical approval from the 
Arnhem/Nijmegen Committee on Research In-
volving Human Subjects in the Netherlands, ref-
erence number of approval CMO-nr: 2001/208.
Results
Participants
Table 1 shows the main characteristics of the 
study population at HNOC intake.10 In decreas-
Table 1. Characteristics of patients at intake at HNOC
Variable n (%)
Age (years)
30–60 39 (57)
61–83 29 (43)
Tumour location
Oral cavity 36 (53)
Oropharynx 25 (37)
Hypopharynx 7 (10)
Tumour stage
T2 37 (54)
T3 19 (28)
T4 12 (18)
Treatment
Radiotherapy 25 (37)
surgery 19 (26)
surgery and radiotherapy 14 (22)
Chemotherapy and radiotherapy 10 (15)
Energy (protein) 
supplements
Yes 23 (34)
no 45 (66)
Tube feeding
nasal passageway 1 (2)
no 67 (98)
T2=tumour between 2 and 4 cm
T3=tumour larger than 4 cm or any size
T4=tumour of any size, but invading adjacent structures.
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ing order the tumour location was the oral 
cavity (53%), oropharynx (37%) and hypopharynx 
(10%). Of all patients, 37 had a tumour sized be-
tween 2 and 4 cm (T2), 19 had a tumour larger 
than 4 cm or any size (T3) and 12 of any size 
invading adjacent structures (T4). Most patients 
were treated by radiotherapy (37%), surgery 
(26%) or a combination of these two (22%). The 
remaining participants were treated by chemo-
therapy and radiotherapy. At the first HNOC 
visit, 23 (34%) patients used energy (protein) 
supplements, of which two were referred by the 
GP and 20 by specialists in regional hospitals or 
the HNOC. The one patient with tube feeding 
received the tube through another specialisation 
within the HNOC.
Figure 1 presents the participant flow during 
HNOC and GPs’ care. In total, 24 patients died 
before the study was extended to general practice. 
The mean overall survival was 65% in one and a 
half years (range 0.9–2.0 years, SD 0.3). Of the 
44 patients remaining, eight declined participa-
tion, four were untraceable and six participated in 
the medical record analysis, but not in the weight 
monitoring. Finally, in total 26 participants were 
monitored. One participant dropped out during 
treatment because of another malignancy in her 
lungs. She was at risk for an impaired nutritional 
status (7% weight loss in three months). Before 
referral, 45 participants’ medical records could be 
analysed; of this number, 26 were available fol-
lowing HNOC care.
Weight monitoring
Due to participants’ personal and follow-up 
circumstances we were able to collect 53 of the 
104 weight measurements. Among the 26 par-
ticipants, 10 suffered from hypertension or other 
cardiovascular risk factors or diseases, four from 
myocardial infarction, five from alcohol abuse 
or related (chronic) diseases, five from digestive 
disorders, two from diabetes, two from gout, two 
from psychiatric disorders, two from another 
kind of cancer and one from hepatitis.
Table 2 displays the percentages of weight 
change after HNOC care. Two participants lost 
between five and 10% of their previous weight 
in three months; one between the sixth and the 
ninth month, the other between the ninth and 
* dead
§ Alive
number of medical records one year before referral (in orange italics) and one year after HnOC-care (in black italics)
*n=12 (7)
non-participants n=8
Untraceable n=4 drop out n=1 (1, 1)
GPs’ medical records
(1 year before referral n=45,
1 year after HNOC-care n=26)
*n=1 (1)
§n=24 (22, 21)
no Yes
1st 2nd 3rd 4th
Participation in 
general practice
n=44
Patients in 
HnOC care
n=68
weight monitoring
n=26
Figure 1. Participant flow during the HNOC and extended general practice study
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the twelfth month of follow-up. The first suf-
fered from lung cancer (BMI 13.4 kg/m2) and the 
latter had an infection (BMI 23.6 kg/m2). None 
of the participants lost 10% or more of their 
previous weight in three or six months. At the 
final measurement, the mean BMI was 23.5 kg/
m2 (n=25, SD 4.6, range 16.8–37.0 kg/m2) and 
three participants (12%) had a BMI <18.5 kg/m2. 
In general, participants gained weight during 
follow-up intervals, ranging from a stable weight 
up to 2% weight increase.
Nutritional information
The GP referred 35 of the 68 (51%) participants. For 
24 of them referral letters were available, in which 
two (8%) GPs documented weight loss or the BMI 
and four (17%) nutrition-related complaints. In 11 
(46%) cases a (pre-) malignancy was suspected.
Table 3 presents the GPs’ documentation of 
weight loss or the BMI, nutrition-related com-
plaints and interventions in medical records. 
Before referral, 20% of the GPs reported weight 
loss or the BMI versus 16% after HNOC care. 
For nutrition-related complaints and interven-
tion this was 13% versus 19% and 7% versus 
19% respectively. There was no substantial 
difference observed in documentation of this 
information in medical records, before referral 
versus after HNOC care. Excluding documenta-
tion related to co-morbidity altered the results 
for nutrition-related complaints and interven-
tions; these were more frequently documented 
after HNOC care (p=0.004).
Discussion
Patients remained vulnerable to an impaired 
nutritional status after specialists’ care. In the 
minority of the patients, GPs documented weight 
loss or the BMI in referral letters and medical 
records before and after HNOC care. Although 
nutrition-related complaints and interventions 
due to head and neck cancer were documented 
more after HNOC care, this was not the case for 
the assessment of patients’ nutritional status by 
weight loss or the BMI.
This is the first in-depth analysis of GPs’ docu-
mentation concerning the nutritional status. Al-
though this study concerns Dutch GPs, literature 
supports the need for nutritional attention in 
primary care in other Western countries.11–13
This study is limited insofar as the only param-
eters used to measure an impaired nutritional 
status were weight loss and the BMI. Weight loss 
could have been masked by fluid retention due 
Table 2. Percentages of weight change within follow-up intervals until one year after 
HNOC care
Variable
Follow-up interval (months)
0–3 3–6 6–9 9–12
n 4 4 9 14
Mean % weight change (sD) 2.3 (3.8) 0.0 (2.4) 1.8 (3.9) 0.3 (2.7)
Maximum % weight loss 3.2 2.5 7.0* 6.7*
Maximum % weight increase 4.8 3.2 5.0 4.5
* ‘At risk’ for an impaired nutritional status (n=1).
sd=standard deviation
Table 3. General practitioners’ documentation of the nutritional status, nutrition-related complaints and interventions in 
medical records
Variable Before referral (n (%)) After HNOC care (n (%))
Yes no Yes no
weight loss or BMI
History Measured History Measured
4 (9) 5 (11)* 36 (80) 2 (8) 2 (8) 22 (84)
nutrition-related 
complaints**
6 (13)§ 39 (87) 5 (19)† 21 (81)
nutritional intervention** 3 (7)‡ 42 (93) 5 (19)|| 21 (81)
‡ ,* ,§ including cases due to comorbidity (n=1, 2, 4, respectively)
† including cases with tube feeding (n=2)
|| Guidance by hospital dietician during treatment for lung cancer (n=1)
** p<0.05 after exclusion of documentation related to comorbidity
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to comorbidity. No questionnaires or laboratory 
measurements have been performed to trace the 
actual occurrence of nutritional deficiency or 
other cachexia-related changes, such as its inflam-
matory activity leading to catabolism of body cell 
mass.14 The difficulty is that no uniform param-
eter exists to qualify the nutritional status. An-
other point is the limited number of participants, 
due to the rarity and poor survival rates of head 
and neck cancer. The mean overall survival in our 
study was representative; in the literature two-
year survival ranges from 50 to 65% for resect-
able15,16 and 23 to 26% for inoperable tumours.17,18 
The three-monthly weight measurements might 
have caused fewer weight measurements on the 
GPs’ own initiative in usual care.
Our study has implications for daily practice. 
Comorbidity can both cause a diminished nu-
tritional status and result from it. For example, 
an infection can induce fever, anorexia and, as a 
consequence, weight loss, or the infection can be 
the result of an impaired immune function due 
to a deficient nutritional intake.19 Optimising 
patient’s nutritional status, next to treating its 
causes or consequences, can prevent a vicious cir-
cle of negative occurrences. Therefore, mention-
ing swallowing or food passage difficulties and 
body weight or weight change in referral letters 
is important for early treatment of cachexia in 
hospitals. Since the GPs might have pre-morbid 
weight documentation, they can transmit valu-
able information to specialists. Specialists, in 
turn, should report nutritional information back 
to guarantee continuity of care.
In future research, more detailed nutritional 
information should be gathered by question-
naires, the occurrence of muscle mass depletion 
over time or even laboratory values in primary 
care patient groups at risk. Qualitative research 
in GPs on the awareness of cachexia and related 
thoughts could shed light on the current poor 
documentation.
In conclusion, we call for nutritional management 
in general practice by urging practitioners to as-
sess patients’ nutritional status in high risk groups 
throughout the disease course and intervene if 
necessary. Transferring related information in case 
of referral promotes continuity of care.
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